The Sunshine Coast Chapter of Mind Medicine Australia is proud to invite you to:

A New Treatment Paradigm for Mental Illness: Psychedelic-Assisted Therapies with Tania de Jong AM & Peter Hunt AM (feat Q&A)

LIMITED TICKETS AVAILABLE

As you may know, Psychedelic-Assisted therapy is showing incredible promise to help people suffering from a range of mental health conditions including PTSD, depression, anxiety and addiction.

We are delighted to invite you to a live in-person event on July 21 in Noosa Heads where you can learn about this exciting new frontier for mental health.

The evening will feature a live presentation and Q&A with the Executive Director and Chairman of Mind Medicine Australia: Tania De Jong AM & Peter Hunt AM.

They will be discussing this exciting new field, which is promising to allow Australians who are suffering from mental illness the opportunity to get well and return to living full lives. They will also be updating those present on recent developments in Australia including the potential rescheduling of Psilocybin and MDMA, the training of therapists and more.

Catering services will be provided on the night.

Date: Thursday 21st July 2022 
Time: 6:00pm (supper and drinks) for 6:30pm start – 8:30pm (includes Q&A Panel)
 Location: Will be provided upon ticket purchase

Ticket Price (incl. Canapés, Non-Alcoholic Drinks and Q&A): $20 General Admission / $10 Concession

Limited tickets available

------------------------------------------------------------------
About the Speakers

Tania De Jong

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 3 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.

Peter Hunt AM

Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years. He co-founded and was Executive Chairman of one of Australia’s leading investment banking advisory firms, Caliburn Partnership (now called Greenhill Australia) and continued as Chairman of the Firm after its sale to Greenhill Inc in 2009. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world. He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He founded Women’s Community Shelter in 2011 and remains on the Board. He was previously Chairman of So They Can, Grameen Australia and Grameen Australia Philippines. Peter is a Director of Project Rozana and an Advisory Board member of the Monash Sustainable Development Institute. Peter also acts as a pro bono adviser to Creativity Australia.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

------------------------------------------------------------------

More about psychedelic-assisted therapy

Psychedelic-assisted therapies offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety, and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer a substantial advantage over current treatments.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

------------------------------------------------------------------

Many thanks to Mind Medicine Australia's Sunshine Coaster Chapter for running this event. Click here for more details or to join the Chapter!

Please support psychedelic research and therapy development by donating to Mind Medicine Australia. The recent pandemic has exacerbated Australia’s mental health epidemic and these treatments have the potential to cure millions of people who are suffering.

We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.